The newest outpatient and inpatient neurology practices are covered in Harvard 31st Annual Update In Neurology 2023. Education incorporates the latest recommendations, therapeutic tactics, and developments, such as genetic tests, optimal imaging, new diagnosis methods, and extended neurological illness treatment options.
Patient outcomes are the focus of hands-on education. The program gives you tools to treat common, complex, and rare neurological illnesses with guidance from neurology subspecialists. Updates provide practice recommendations to improve patient care and outcomes.
Audience target:
- Physicians should attend.
- Medical professionals
- Health professionals
- Health professionals
Learning Objectives of Harvard 31st Annual Update In Neurology 2023:
After Harvard 31st Annual Update In Neurology, attendees can:
- Apply the latest research and guidelines to prevalent neurological diseases in inpatient treatment.
- Discuss basic neurological treatment in low-resource settings.
- Diagnose and treat immune-mediated neurological disorders.
- Discover the main causes of neurological diagnosis and treatment of cognitive errors.
- Determine seizure types and mimics.
- Identify and treat common and unusual headaches and vertigo.
- A brief stroke prevention and management guide.
- Effectively detecting and treating complex neurologic disorders in outpatient and inpatient settings.
Program of Harvard 31st Annual Update In Neurology 2023:
Monday, October 9, 2023
Introduction
Updates In Alzheimer’s Disease
Dennis J. Selkoe, MD
Q&A
State-Of-The Art Approaches To The Diagnosis Of Dementia
Scott M. McGinnis, MD
Q&A
State-Of-The-Art Approaches In The Treatment Of Dementia
Seth A. Gale, MD
Q&A
State-Of-The-Art Diagnosis Of Demyelinating Disease, MS, NMOSD, And MOGAD
Tanuja Chitnis, MD
Q&A
Break
Coma And Disorders Of Consciousness*
Martin A. Samuels, MD
Q&A
Updates In The Diagnosis And Medical Management Of Parkinsonism
Albert Y. Hung, MD, PhD
Q&A
Non-Pharmacologic Therapy Of Movement Disorders
Michael T. Hayes, MD
Q&A
Advances In Our Understanding Of Hyperkinetic Movements
Edison K. Miyawaki, MD
Q&A With Course Directors
Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD
Tuesday, October 10, 2023
Concussion And Sports-Related Neurological Injuries: Guidance To Improve Patient Outcomes
Claus Reinsberger, MD
Q&A
Visual Disturbances
Sashank Prasad, MD
Q&A
State-Of-The-Art Approaches In Stroke Prevention And Treatment Prevention And Treatment
Mariel G. Kozberg, MD, PhD
Q&A
Updates In Genetics Of Cerebrovascular Disease
Patricia L. Musolino, MD, PhD
Q&A
Break
Current Approach To Myopathies
Vijay S. Ganesh, MD, PhD
Q&A
Keynote: How Neurologists Think: What My Errors Taught Me*
Martin A. Samuels, MD
Q&A
Neurologic Emergencies: Quick Identification And Steps To Optimize Patient Outcomes
Bradley J. Molyneaux, MD, PhD
Q&A
Brain Tumors In 2023: State-Of-The-Art And Emerging Treatment Options
Tracy T. Batchelor, MD, MPH
Q&A With Course Directors
Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD
Wednesday, October 11, 2023
Best Practices For Diagnosing And Managing Psychogenic Non-Epileptic Seizures
Barbara A. Dworetzky, MD
Q&A
Challenging Epilepsy Cases In Pregnancy
Paula Emanuela Voinescu, MD
Q&A
Updates In Pharmacological Treatment Of Epilepsy
Jong Woo Lee, MD, PhD
Q&A
New Concepts In Non-Pharmacologic Treatment Of Epilepsy
Ellen J. Bubrick, MD
Q&A
Break
Studying Functional Networks And Targeting Stimulation Treatment Of Neuropsychiatric Diseases
Michael D. Fox, MD, PhD
Q&A
Neurogenetics And Impact On Clinical Practice
Scott R. Plotkin, MD, PhD
Q&A
Below-The-Belt Neurology: Bladder, Bowel & Sexual Dysfunction
Tamara Kaplan, MD
Q&A
Keynote: State-Of-The-Art Treatment Of ALS
James D. Berry, MD, MPH
Q&A With Course Directors
Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD
Thursday, October 12, 2023
Neurological Complications Of Checkpoint Inhibition And Other Immunotherapies In Cancer Patients
Isabel Arrillaga-Romany, MD, PhD
Q&A
Evolving Uses Of Imaging In Neurology
Joshua P. Klein, MD, PhD
Q&A
Optimizing Your Approach To Treating Multiple Sclerosis
Eric C. Klawiter, MD
Q&A
Modern Diagnosis And Treatment Of Cerebellar Ataxias
Jeremy D. Schmahmann, MD
Q&A
Break
Update On Diagnosing And Treating Eye Movement Disorders
Robert M. Mallery, MD
Q&A
Neurology Of Skull Base Lesions
Bart K. Chwalisz, MD
Q&A
Treating Neurological Cancer
Eudocia Quant Lee, MD, MPH
Q&A
Alcohol Associated Neurological Disorders
Michael E. Charness, MD
Q&A with Course Directors
Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD
Friday, October 13, 2023
Neuropathy And Neuromuscular Junction: Cases Offering Clinical Pearls
Christopher T. Doughty, MD
Q&A
Updates In The Neurologic Impact Of COVID
Giovanna S. Manzano, MD
Q&A
Contemporary Issues In Women’s Neurology
Mary Angela O’Neal, MD
Q&A
Neuroprognotication, Coma And Recovery
Michael J. Young, MD
Q&A
Break
Unusual And Difficult Cases Of Headache-Diagnostic Challenges
Brian E. McGeeney, MD, MPH, MBA
Q&AÂ
Delivering The Best Care For Neck And Back Pain
Shamik Bhattacharyya, MD
Q&A
New Treatment Options For Migraine
Elizabeth W. Loder, MD, MPH
Q&AÂ
Treating Headache With Integrative Therapies
Carolyn A. Bernstein, MD
Lessons In Global Neurology
Farrah J. Mateen, MD, PhD
Q&A With Course Directors
Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD
See Also: 3rd Annual Alzheimer’s Disease, Lewy Body And Related Dementias Symposium 2023
Reviews
There are no reviews yet.